Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure

JOHN W. OSTROMINSKI, RAHUL AGGARWAL, BRIAN L. CLAGGETT, IAN J. KULAC, AKSHAY S. DESAI, PARDEEP S. JHUND, CAROLYN S.P. LAM, BERTRAM PITT, MICHELE SENNI, SANJIV J. SHAH, ADRIAAN A. VOORS, FAIEZ ZANNAD, JAMES LAY-FLURRIE, PRABHAKAR VISWANATHAN, JOHN J.V. MCMURRAY, SCOTT D. SOLOMON, MUTHIAH VADUGANATHAN*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1170-1174
Number of pages5
JournalJournal of Cardiac Failure
Volume30
Issue number9
DOIs
StatePublished - Sep 2024

Funding

FINEARTS-HF was sponsored by Bayer AG.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this